National Institute of Allergy and Infectious Diseases; Notice of Closed Meetings, 52408 [05-17515]
Download as PDF
52408
Federal Register / Vol. 70, No. 170 / Friday, September 2, 2005 / Notices
This notice is being published less than 15
days prior to the meeting due to the timing
limitations imposed by the review and
funding cycle.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.846, Arthritis,
Musculoskeletal and Skin Diseases Research,
National Institutes of Health, HHS)
Dated: August 26, 2005.
Anthony M. Coelho, Jr.,
Acting Director, Office of Federal Advisory
Committee Policy.
[FR Doc. 05–17463 Filed 9–1–05; 8:45 am]
Bethesda, MD 20817, (Telephone Conference
Call).
Contact Person: Sujata Vijh, PhD, Scientific
Review Administrator, Scientific Review
Program, Division of Extramural Activities,
NIAID/NIH/DHHS, 6700B Rockledge Drive,
MSC 7616, Bethesda, MD 20892, (301) 594–
0985, vijhs@niaid.nih.gov.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.955, Allergy, Immunology
and Transplantation Research; 93.856,
Microbiology and Infectious Diseases
Research, National Institutes of Health, HHS)
Dated: August 25, 2005.
Anthony M. Coelho, Jr.,
Acting Director, Office of Federal Advisory
Committee Policy.
[FR Doc. 05–17515 Filed 9–1–05; 8:45 am]
BILLING CODE 4140–01–M
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
BILLING CODE 4140–01–M
National Institutes of Health
National Institute of Allergy and
Infectious Diseases; Notice of Closed
Meetings
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended (5 U.S.C. Appendix 2), notice
is hereby given of the following
meetings.
The meetings will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: National Institute of
Allergy and Infectious Diseases Special
Emphasis Panel; Review of an Unsolicited
P01.
Date: September 22, 2005.
Time: 10 a.m. to 1 p.m.
Agenda: To review and evaluate grant
applications and/or proposals.
Place: National Institutes of Health,
Rockledge 6700, 6700B Rockledge Drive,
Bethesda, MD 20817, (Telephone Conference
Call).
Contact Person: Cheryl P. Lapham, PhD,
Scientific Review Administrator, Scientific
Review Program, National Institutes of
Allergy and Infectious Diseases, DEA/NIH/
DHHS, 6700B Rockledge Drive, MSC 7616,
Room 3127, Bethesda, MD 20892–7616, 301–
402–4598, clapham@niaid.nih.gov.
Name of Committee: National Institute of
Allergy and Infectious Diseases Special
Emphasis Panel; Minor H Antigens and
Kidney Transplantation.
Date: September 23, 2005.
Time: 2 p.m. to 6 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health,
Rockledge 6700, 6700B Rockledge Drive,
VerDate Aug<18>2005
18:00 Sep 01, 2005
Jkt 205001
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Office of Refugee Resettlement
Final Notice for FY 2005 Formula
Allocation for Targeted Assistance
Grants to States for Services to
Refugees
Office of Refugee Resettlement
(ORR), ACF, HHS.
ACTION: Final notice of availability of
allocations for FY 2005 targeted
assistance grants to States for services to
refugees 1 in local areas of high need.
AGENCY:
[CFDA No. 93.584, Refugee and Entrant
Assistance—Targeted Assistance Grants]
SUMMARY: This final notice announces
the availability of funds and award
procedures for FY 2005 Targeted
Assistance Program (TAP) grants to
States for services to refugees under the
Refugee Resettlement Program (RRP).
These grants are for service provision in
localities with large refugee
populations, high refugee
concentrations, and where specific
needs exist for supplementation of
currently available resources.
1 In addition to persons who meet all
requirements of 45 CFR 400.43, ‘‘Requirements for
documentation of refugee status,’’ eligibility for
targeted assistance includes refugees, asylees,
Cuban and Haitian entrants, certain Amerasians
from Viet Nam who are admitted to the U.S. as
immigrants, certain Amerasians from Viet Nam who
are U.S. citizens and victims of a severe form of
trafficking who receive certification or eligibility
letters from ORR, and certain other specified family
members of trafficking victims. See Section II of this
notice on ‘‘Authorization,’’ and refer to 45 CFR
400.43 and the ORR State Letter #01–13 on the
Trafficking Victims Protection Act dated May 3,
2001, as modified by ORR State Letter #02–01,
January 4, 2002, and ORR State Letter #04–12, June
18, 2004. The term ‘‘refugee,’’ used in this notice
for convenience, is intended to encompass such
additional persons who are eligible to participate in
refugee program services, including the targeted
assistance program.
PO 00000
Frm 00048
Fmt 4703
Sfmt 4703
Qualification of counties for eligibility
for targeted assistance program grants is
determined once every three years as
stated in the FY 1999 Notice of
Proposed Availability of Targeted
Assistance Allocations to States which
was published in the Federal Register
on March 10, 1999 (64 FR 11927). The
FY 2002–FY 2004 three-year project
cycle has expired. FY 2005 is the year
for the re-qualification of counties for
the three-year project cycle, FY 2005,
FY 2006, and FY 2007 for TAP funds.
Qualifications of counties are based on
the arrivals of refugees (see Footnote 1,
eligible population) during the 5-year
period from FY 2000 through FY 2004,
and on the concentration of the arrivals
population as a percentage of the
general population. Counties that
qualify for TAP FY 2005 funds on the
basis of the most current 5-year
population are listed in this proposed
notice in Table 1, Table 2, Table 4, and
Table 6.
Under this final notice, a total of 48
counties (Table 1) qualify for targeted
assistance grants. Of these, 6 new
counties (Table 2) qualify for targeted
assistance grants, and 11 counties (Table
3) which previously received targeted
assistance grants no longer qualify for
targeted assistance program funding.
Application Deadline: Application
deadline for targeted assistance program
funding will be September 12, 2005. A
full application is required this
qualifying year, FY 2005. Six (6) new
counties are eligible for targeted
assistance. Counties that have received
TAP funds in the past and will continue
to qualify for TAP have not been
required to submit a full application
since FY 2002. Application
requirements in the second and third of
a 3-year project cycle will be less
extensive.
FOR FURTHER INFORMATION CONTACT:
Kathy Do, Division of Budget, Policy
and Data Analysis (DBPDA), (202) 401–
4579; e-mail: kdo@acf.hhs.gov.
SUPPLEMENTARY INFORMATION:
I. Purpose and Scope
This final notice announces the
availability of Fiscal Year 2005 funds for
targeted assistance grants for services to
refugees (see Footnote 1 for eligible
population) in counties where, because
of factors such as unusually large
refugee populations and high refugee
concentrations, there exists and can be
demonstrated a specific need for
supplementation of resources for
services to this population.
The Office of Refugee Resettlement
(ORR) has available $49,081,000 in FY
2005 funds for the targeted assistance
E:\FR\FM\02SEN1.SGM
02SEN1
Agencies
[Federal Register Volume 70, Number 170 (Friday, September 2, 2005)]
[Notices]
[Page 52408]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 05-17515]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health
National Institute of Allergy and Infectious Diseases; Notice of
Closed Meetings
Pursuant to section 10(d) of the Federal Advisory Committee Act, as
amended (5 U.S.C. Appendix 2), notice is hereby given of the following
meetings.
The meetings will be closed to the public in accordance with the
provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5
U.S.C., as amended. The grant applications and the discussions could
disclose confidential trade secrets or commercial property such as
patentable material, and personal information concerning individuals
associated with the grant applications, the disclosure of which would
constitute a clearly unwarranted invasion of personal privacy.
Name of Committee: National Institute of Allergy and Infectious
Diseases Special Emphasis Panel; Review of an Unsolicited P01.
Date: September 22, 2005.
Time: 10 a.m. to 1 p.m.
Agenda: To review and evaluate grant applications and/or
proposals.
Place: National Institutes of Health, Rockledge 6700, 6700B
Rockledge Drive, Bethesda, MD 20817, (Telephone Conference Call).
Contact Person: Cheryl P. Lapham, PhD, Scientific Review
Administrator, Scientific Review Program, National Institutes of
Allergy and Infectious Diseases, DEA/NIH/DHHS, 6700B Rockledge
Drive, MSC 7616, Room 3127, Bethesda, MD 20892-7616, 301-402-4598,
clapham@niaid.nih.gov.
Name of Committee: National Institute of Allergy and Infectious
Diseases Special Emphasis Panel; Minor H Antigens and Kidney
Transplantation.
Date: September 23, 2005.
Time: 2 p.m. to 6 p.m.
Agenda: To review and evaluate grant applications.
Place: National Institutes of Health, Rockledge 6700, 6700B
Rockledge Drive, Bethesda, MD 20817, (Telephone Conference Call).
Contact Person: Sujata Vijh, PhD, Scientific Review
Administrator, Scientific Review Program, Division of Extramural
Activities, NIAID/NIH/DHHS, 6700B Rockledge Drive, MSC 7616,
Bethesda, MD 20892, (301) 594-0985, vijhs@niaid.nih.gov.
(Catalogue of Federal Domestic Assistance Program Nos. 93.955,
Allergy, Immunology and Transplantation Research; 93.856,
Microbiology and Infectious Diseases Research, National Institutes
of Health, HHS)
Dated: August 25, 2005.
Anthony M. Coelho, Jr.,
Acting Director, Office of Federal Advisory Committee Policy.
[FR Doc. 05-17515 Filed 9-1-05; 8:45 am]
BILLING CODE 4140-01-M